Composition and method for tank-mixed spray coating of 1-MCP
By adding a gas-containing agent such as α-cyclodextrin to an aqueous solution to form a stable 1-MCP complex, the instability and flammability/explosiveness of 1-MCP gas during storage and transportation are solved, enabling efficient and stable storage and field application in aqueous solution.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-03-15
- Publication Date
- 2026-03-19
AI Technical Summary
The existing 1-MCP gas is unstable during storage and transportation, and is flammable and explosive. The liquid complex releases gas rapidly during storage, making it difficult to use in the field.
A stable composition containing a gas-containing agent is used. By adding a gas-containing agent such as α-cyclodextrin to an aqueous solution, a stable complex is formed, which reduces the release of gaseous 1-MCP during storage and improves safety and stability.
It achieves the maintenance of a high concentration of 1-MCP in aqueous solution, reduces the release of gaseous 1-MCP during storage, improves safety and stability, and is suitable for field use.
Smart Images

Figure 2026509500000001_ABST
Abstract
Description
Technical Field
[0001] Cross - reference to related applications This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 63 / 452,240, filed on Mar. 15, 2023, the entire disclosure of which is hereby incorporated by reference herein.
Background Art
[0002] Cyclopropene compounds such as 1 - methylcyclopropene (1 - MCP) are useful for treating plants or plant parts. However, gaseous 1 - MCP is difficult to handle and store, and is flammable when the concentration exceeds 13,300 parts per million (ppm). As a result, in current agricultural applications, 1 - MCP can be stabilized in a complex with, for example, molecular encapsulating agents, complexing agents, inclusion agents, etc. As an example, 1 - MCP can be stabilized within an inclusion compound such as α - cyclodextrin (alpha - cyclodextrin or α - CD) to facilitate handling during storage and transportation.
[0003] By contacting the complexed cyclopropene with a solvent (e.g., tap water), cyclopropene molecules can be released from the complex into space. As a result, liquid (especially aqueous) formulations of complexed cyclopropene compounds are generally unstable for storage purposes. When contacted with water or even moisture, 1 - MCP gas is rapidly released at a rate that is not suitable for tank use because most of the gas is lost within the headspace of the tank before the product has an opportunity to be sprayed in the field.
[0004] Therefore, there remains a need to develop stable formulations for the storage of volatile compounds such as 1 - MCP, especially for field applications.
Summary of the Invention
Means for Solving the Problems
[0005] This disclosure provides both solid and aqueous compositions, as well as methods thereof, that address known problems in the art by incorporating a gas containment agent. The compositions and methods of this disclosure allow for the presence of a larger amount of solvent, such as water, in the aqueous composition so that a substantial portion of 1-MCP can be retained in the aqueous composition before application to a plant or plant part. Furthermore, the compositions and methods provide improved safety of the aqueous composition in that a lower concentration of gaseous 1-MCP is present in the upper space of the tank or container, thereby minimizing flammability.
[0006] Other objects, features, and effects of the present invention will become apparent from the following detailed description. However, it should be understood that the detailed description and specific examples illustrate particular embodiments of the present invention, but are given only as examples, as various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description. [Brief explanation of the drawing]
[0007] For detailed explanations, please refer particularly to the attached drawings.
[0008] [Figure 1] Figure 1 shows the concentration (ppm) of 1-MCP present in the upper space of the container at various gas-containing agents ("auxiliaries") and administration levels.
[0009] [Figure 2] Figure 2 shows the percentage of 1-MCP remaining in the solution at various gas-containing agents ("adjuvants") and administration levels.
[0010] [Figure 3] Figure 3 shows the concentration (ppm) of 1-MCP present in the upper space of the container at various gas-containing agents ("auxiliaries") and administration levels.
[0011] [Figure 4] Figure 4 shows the classification of covering colors analyzed for the fruit.
[0012] [Figure 5] Figure 5 shows the color distribution of the fruit at harvest H0.
[0013] [Figure 6] Figure 5 shows the color distribution of the fruit seven days after commercial harvest (H+7).
[0014] [Figure 7] Figure 7 shows the color distribution of the fruit 14 days after commercial harvest (H+14). [Modes for carrying out the invention]
[0015] In one embodiment for illustrative purposes, an aqueous composition is provided. The aqueous composition comprises i) 1-MCP, ii) a gas containment agent, and iii) water. In various embodiments, the aqueous composition may be a premixed composition in which 1-MCP and the gas containment agent are combined with water at the time of use (e.g., backpack spraying, drone spraying, etc.). Alternatively, in various embodiments, the aqueous composition may be a tank mixture composition in which 1-MCP is combined with the gas containment agent and water at the time of use (e.g., in the field).
[0016] In one embodiment, 1-MCP is included in the complex. In one embodiment, the complex is an inclusion compound. In one embodiment, the inclusion compound contains cyclodextrin. In one embodiment, the inclusion compound contains alphacyclodextrin. In one embodiment, the inclusion compound is essentially made of alphacyclodextrin. In one embodiment, the inclusion compound consists of alphacyclodextrin.
[0017] In one embodiment, the gas containment agent is derived from an inclusion compound. In one embodiment, the composite is suspended as solid particles in an aqueous composition. In one embodiment, the solid particle size is approximately 0.5 μm to approximately 30 μm on average.
[0018] In one embodiment, the complex is air pulverized. In one embodiment, the complex is solubilized in an aqueous composition.
[0019] In one embodiment, the complex is present at a concentration of about 0.1 wt% to about 50 wt% in the aqueous composition. In one embodiment, the complex is present at a concentration of about 0.5 wt% to about 30 wt% in the aqueous composition. In one embodiment, the complex is present at a concentration of about 0.5 wt% to about 20 wt% in the aqueous composition. In one embodiment, the complex is present at a concentration of about 0.5 wt% to about 10 wt% in the aqueous composition. <000008....(注:原文中
[0020] 至 部分内容不完整,翻译时保留原样) In one embodiment, 1-MCP is included in the solution. In one embodiment, 1-MCP is present in the solution at about 0.1% to about 1.0%. In one embodiment, 1-MCP is present in the solution at about 1% to about 2%. In one embodiment, 1-MCP is present in the solution at about 2% to about 3%. In one embodiment, 1-MCP is present in the solution at about 3% to about 4%. In one embodiment, 1-MCP is present in the solution at about 4% to about 5%.
[0021] In one embodiment, 1-MCP is present in the solution at a concentration of about 1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.3%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.4%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.5%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.6%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.7%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.8%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.9%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.3%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.4%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.5%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.6%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.7%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.8%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.9%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3.1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3.2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3.3%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.4%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.5%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.6%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.7%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.8%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.9%.In one embodiment, 1-MCP is present in the solution at about 4%. In one embodiment, 1-MCP is present in the solution at about 4.1%. In one embodiment, 1-MCP is present in the solution at about 4.2%. In one embodiment, 1-MCP is present in the solution at about 4.3%. In one embodiment, 1-MCP is present in the solution at about 4.4%. In one embodiment, 1-MCP is present in the solution at about 4.5%. In one embodiment, 1-MCP is present in the solution at about 4.6%. In one embodiment, 1-MCP is present in the solution at about 4.7%. In one embodiment, 1-MCP is present in the solution at about 4.8%. In one embodiment, 1-MCP is present in the solution at about 4.9%. In one embodiment, 1-MCP is present in the solution at about 5%.
[0022] In one embodiment, 1-MCP is included in the powder. In one embodiment, the powder is a wettable powder. As used herein, a wettable powder refers to a powder that can be wetted with a liquid, such as water. In certain aspects, a wettable powder refers to a powder containing 1-MCP in which the addition of a liquid does not release a substantial amount of gaseous 1-MCP from the powder. In one embodiment, 1-MCP is present in the powder at about 0.1% to about 1.0%. In one embodiment, 1-MCP is present in the powder at about 1% to about 2%. In one embodiment, 1-MCP is present in the powder at about 2% to about 3%. In one embodiment, 1-MCP is present in the powder at about 3% to about 4%. In one embodiment, 1-MCP is present in the powder at about 4% to about 5%.
[0023] In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.9%.In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 5%.
[0024] As described herein, gas containment agent means a component that can prevent or reduce the release of gaseous material (e.g., gaseous 1-MCP) into the upper space of a container or vessel. Alternatively, or further, gas containment agent means a component that can prevent or reduce the release of gaseous material (e.g., gaseous 1-MCP) into the atmosphere, thereby preventing or reducing at least one of the loss of gaseous material in an aqueous composition and the loss of retention of gaseous material before its final use or application to achieve agricultural benefits. In one embodiment, the gas containment agent is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieves, and any combination thereof. In one embodiment, the gas containment agent comprises alpha-cyclodextrin. In one embodiment, the gas containment agent comprises activated carbon (charcoal). In one embodiment, the gas containment agent comprises activated carbon (carbon). In one embodiment, the gas containment agent comprises porous silica. In one embodiment, the gas containment agent includes a molecular sieve.
[0025] In one embodiment, the gas containment agent is about 0.1% to about 50% by weight of water in the aqueous composition. In one embodiment, the gas containment agent is about 1% to about 30% by weight of water in the aqueous composition. In one embodiment, the gas containment agent is about 2% to about 20% by weight of water in the aqueous composition. In one embodiment, the gas containment agent is about 2.5% to about 15% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 1% to about 10% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 3% to about 10% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 1% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 2% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 3% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 4% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 5% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 6% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 7% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 8% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 9% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 10% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 11% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 12% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 13% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 14% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 15% by weight of water in the aqueous composition.
[0026] In one embodiment, the total amount of 1-MCP in the aqueous composition is maintained at at least 10% by weight of the initial amount of 1-MCP for 24 hours. In one embodiment, the total amount of 1-MCP in the aqueous composition is maintained at at least 25% by weight of the initial amount of 1-MCP for 24 hours. In one embodiment, the total amount of 1-MCP in the aqueous composition is maintained at at least 50% by weight of the initial amount of 1-MCP for 24 hours. In one embodiment, the total amount of 1-MCP in the aqueous composition is maintained at at least 75% by weight of the initial amount of 1-MCP for 24 hours.
[0027] In one embodiment, the aqueous composition further comprises a water conditioner, a metal chelating agent, a pH adjuster, a biocide, a preservative, a surfactant, a dispersant, a wetting agent, a spraying aid, a polymer, or any combination thereof. In another embodiment, the aqueous composition further comprises a fungicide, an insecticide, a herbicide, a fertilizer, a nutrient, or any combination thereof.
[0028] In one embodiment for illustrative purposes, the solid composition comprises i) 1-MCP and ii) a gas containment agent.
[0029] In one embodiment, 1-MCP is included in the complex. In one embodiment, the complex is an inclusion compound. In one embodiment, the inclusion compound contains cyclodextrin. In one embodiment, the inclusion compound contains alphacyclodextrin. In one embodiment, the inclusion compound is essentially made of alphacyclodextrin. In one embodiment, the inclusion compound consists of alphacyclodextrin.
[0030] In one embodiment, the gas containment agent is derived from an inclusion compound. In one embodiment, the composite exists as solid particles in a solid composition. In one embodiment, the solid particle size is on average about 0.5 μm to about 30 μm.
[0031] In one embodiment, the composite is air-pulverized. In one embodiment, the composite is about 2% to about 90% by weight of the total composition.
[0032] In one embodiment, 1-MCP is contained in a powder. In one embodiment, the powder is a wettable powder. In one embodiment, 1-MCP is present in the powder at a concentration of about 0.1% to about 1.0%. In one embodiment, 1-MCP is present in the powder at a concentration of about 1% to about 2%. In one embodiment, 1-MCP is present in the powder at a concentration of about 2% to about 3%. In one embodiment, 1-MCP is present in the powder at a concentration of about 3% to about 4%. In one embodiment, 1-MCP is present in the powder at a concentration of about 4% to about 5%.
[0033] In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.9%.In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 5%.
[0034] In one embodiment, the gas containment agent is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieve, and any combination thereof. In one embodiment, the gas containment agent includes alpha-cyclodextrin. In one embodiment, the gas containment agent includes activated carbon (charcoal). In one embodiment, the gas containment agent includes activated carbon (carbon). In one embodiment, the gas containment agent includes porous silica. In one embodiment, the gas containment agent includes molecular sieve.
[0035] In one embodiment, the gas containment agent is about 10% to about 98% by weight of the whole composition. In one embodiment, the aqueous composition further comprises water conditioners, metal chelating agents, pH adjusters, biocides, preservatives, surfactants, dispersants, wetting agents, spraying aids, polymers, or any combination thereof. In one embodiment, the aqueous composition further comprises fungicides, insecticides, herbicides, fertilizers, nutrients, or any combination thereof. In one embodiment, the solid composition can be diluted with water to form an aqueous composition.
[0036] In one embodiment for illustrative purposes, a method for preparing an aqueous composition is provided. The method includes a) adding water to a container, b) adding a gas containment agent to the container, c) adding 1-MCP to the container, and d) mixing the water, gas containment agent, and 1-MCP to form an aqueous composition.
[0037] In one embodiment, step c) is performed simultaneously with step b). In one embodiment, step c) is performed after step b). In one embodiment, mixing is performed until the aqueous composition is homogeneous. In various embodiments, the aqueous composition may be a premixed composition in which 1-MCP and gas containment agent are combined with water at the time of use (e.g., backpack spraying, drone spraying, etc.). Alternatively, in various embodiments, the aqueous composition may be a tank mixture composition in which 1-MCP is combined with the gas containment agent and water at the time of use (e.g., in the field).
[0038] In one embodiment, 1-MCP is included in the complex. In one embodiment, the complex is an inclusion compound. In one embodiment, the inclusion compound contains cyclodextrin. In one embodiment, the inclusion compound contains alphacyclodextrin. In one embodiment, the inclusion compound is essentially made of alphacyclodextrin. In one embodiment, the inclusion compound consists of alphacyclodextrin.
[0039] In one embodiment, the gas containment agent is derived from an inclusion compound. In one embodiment, the composite is suspended as solid particles in an aqueous composition. In one embodiment, the solid particle size is approximately 0.5 μm to approximately 30 μm on average.
[0040] In one embodiment, the composite is pulverized with air. In one embodiment, the composite is solubilized in an aqueous composition. In one embodiment, the composite is present at a concentration of about 0.1% to about 50% by weight of the aqueous composition. In one embodiment, the composite is present at a concentration of about 0.5% to about 30% by weight of the aqueous composition. In one embodiment, the composite is present at a concentration of about 0.5% to about 20% by weight of the aqueous composition. In one embodiment, the composite is present at a concentration of about 0.5% to about 10% by weight of the aqueous composition.
[0041] In one embodiment, 1-MCP is present in the solution. In one embodiment, 1-MCP is present in the solution at a concentration of about 0.1% to about 1.0%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1% to about 2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2% to about 3%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3% to about 4%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4% to about 5%.
[0042] In one embodiment, 1-MCP is present in the solution at a concentration of about 1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.3%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.4%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.5%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.6%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.7%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.8%. In one embodiment, 1-MCP is present in the solution at a concentration of about 1.9%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.3%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.4%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.5%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.6%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.7%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.8%. In one embodiment, 1-MCP is present in the solution at a concentration of about 2.9%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3.1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3.2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 3.3%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.4%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.5%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.6%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.7%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.8%. In one embodiment, 1-MCP is present in the solution at a concentration of approximately 3.9%.In one embodiment, 1-MCP is present in the solution at a concentration of about 4%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.1%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.2%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.3%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.4%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.5%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.6%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.7%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.8%. In one embodiment, 1-MCP is present in the solution at a concentration of about 4.9%. In one embodiment, 1-MCP is present in the solution at a concentration of about 5%.
[0043] In one embodiment, 1-MCP is contained in a powder. In one embodiment, the powder is a wettable powder. In one embodiment, 1-MCP is present in the powder at a concentration of about 0.1% to about 1.0%. In one embodiment, 1-MCP is present in the powder at a concentration of about 1% to about 2%. In one embodiment, 1-MCP is present in the powder at a concentration of about 2% to about 3%. In one embodiment, 1-MCP is present in the powder at a concentration of about 3% to about 4%. In one embodiment, 1-MCP is present in the powder at a concentration of about 4% to about 5%.
[0044] In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.9%.In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 5%.
[0045] In one embodiment, the gas containment agent is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieve, and any combination thereof. In one embodiment, the gas containment agent includes alpha-cyclodextrin. In one embodiment, the gas containment agent includes activated carbon (charcoal). In one embodiment, the gas containment agent includes activated carbon (carbon). In one embodiment, the gas containment agent includes porous silica. In one embodiment, the gas containment agent includes molecular sieve.
[0046] In one embodiment, the gas containment agent is about 0.1% to about 50% by weight of water in the aqueous composition. In one embodiment, the gas containment agent is about 1% to about 30% by weight of water in the aqueous composition. In one embodiment, the gas containment agent is about 2% to about 20% by weight of water in the aqueous composition. In one embodiment, the gas containment agent is about 2.5% to about 15% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 1% to about 10% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 3% to about 10% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 1% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 2% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 3% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 4% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 5% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 6% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 7% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 8% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 9% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 10% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 11% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 12% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 13% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 14% by weight of water in the aqueous composition. In one embodiment, the gas scavenger is about 15% by weight of water in the aqueous composition.
[0047] In one embodiment, the aqueous composition further comprises a water conditioner, a metal chelating agent, a pH adjuster, a biocide, a preservative, a surfactant, a dispersant, a wetting agent, a spraying aid, a polymer, or any combination thereof. In another embodiment, the aqueous composition further comprises a fungicide, an insecticide, a herbicide, a fertilizer, a nutrient, or any combination thereof.
[0048] In one embodiment for illustrative purposes, a method for preparing a solid composition is provided. The method includes a) adding a gas containment agent to a container, b) adding 1-MCP to the container, and c) mixing the gas containment agent and 1-MCP to form a solid composition.
[0049] In one embodiment, mixing is carried out until the solid composition is homogeneous.
[0050] In one embodiment, 1-MCP is included in the complex. In one embodiment, the complex is an inclusion compound. In one embodiment, the inclusion compound contains cyclodextrin. In one embodiment, the inclusion compound contains alphacyclodextrin. In one embodiment, the inclusion compound is essentially made of alphacyclodextrin. In one embodiment, the inclusion compound consists of alphacyclodextrin.
[0051] In one embodiment, the gas containment agent is derived from an inclusion compound. In one embodiment, the composite exists as solid particles in a solid composition. In one embodiment, the solid particle size is on average about 0.5 μm to about 30 μm.
[0052] In one embodiment, the composite is air-pulverized. In one embodiment, the composite is about 2% to about 90% by weight of the total composition.
[0053] In one embodiment, 1-MCP is contained in a powder. In one embodiment, the powder is a wettable powder. In one embodiment, 1-MCP is present in the powder at a concentration of about 0.1% to about 1.0%. In one embodiment, 1-MCP is present in the powder at a concentration of about 1% to about 2%. In one embodiment, 1-MCP is present in the powder at a concentration of about 2% to about 3%. In one embodiment, 1-MCP is present in the powder at a concentration of about 3% to about 4%. In one embodiment, 1-MCP is present in the powder at a concentration of about 4% to about 5%.
[0054] In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 1.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 2.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 3.9%.In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.1%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.2%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.3%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.4%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.5%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.6%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.7%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.8%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 4.9%. In one embodiment, 1-MCP is present in the powder at a concentration of approximately 5%.
[0055] In one embodiment, the gas containment agent is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieve, and any combination thereof. In one embodiment, the gas containment agent includes alpha-cyclodextrin. In one embodiment, the gas containment agent includes activated carbon (charcoal). In one embodiment, the gas containment agent includes activated carbon (carbon). In one embodiment, the gas containment agent includes porous silica. In one embodiment, the gas containment agent includes molecular sieve.
[0056] In one embodiment, the gas containment agent is about 10% to about 98% by weight of the whole composition. In one embodiment, the aqueous composition further comprises water conditioners, metal chelating agents, pH adjusters, biocides, preservatives, surfactants, dispersants, wetting agents, spraying aids, polymers, or any combination thereof. In one embodiment, the solid composition further comprises fungicides, insecticides, herbicides, fertilizers, nutrients, or any combination thereof.
[0057] In one embodiment, the solid composition is a granular mixture. In another embodiment, the solid composition is a powder mixture. In another embodiment, the powder mixture can be granulated.
[0058] In one embodiment for illustrative purposes, a method for applying an aqueous composition to a plant or plant part is provided. The method includes the step of administering the aqueous composition to the plant or plant part via an agricultural tool.
[0059] In one embodiment, the agricultural machinery includes a ground spraying device. In one embodiment, the agricultural machinery includes an aerial spraying device. In one embodiment, the agricultural machinery includes a drone spraying device. In one embodiment, the agricultural machinery includes a backpack spraying device.
[0060] In one embodiment, the agricultural equipment includes a spray tank or container. In one embodiment, the spray tank or container is ventilated.
[0061] In one embodiment, the aqueous composition is prepared in situ. In one embodiment, the aqueous composition is an aqueous composition relating to any aqueous composition described herein. In one embodiment, the aqueous composition is prepared according to any of the methods described herein.
[0062] The following numbered embodiments are intended and are not limiting. 1. An aqueous composition comprising i) 1-MCP, ii) a gas scavenger, and iii) water. 2.1- An aqueous composition comprising item 1, other suitable items, or any combination of suitable items, wherein MCP is included in the complex. 3. An aqueous composition of item 2, any other suitable item, or any combination of suitable items, wherein the complex is an inclusion compound. 4. An aqueous composition of item 3, another suitable item, or any combination of suitable items, wherein the inclusion compound comprises cyclodextrin. 5. An aqueous composition of item 3, another suitable item, or any combination of suitable items, wherein the inclusion compound comprises alpha-cyclodextrin. 6. An aqueous composition of item 3, other suitable items, or any combination of suitable items, wherein the inclusion compound essentially consists of alpha-cyclodextrin. 7. An aqueous composition of item 3, another suitable item, or any combination of suitable items, wherein the inclusion compound comprises alpha-cyclodextrin. 8. An aqueous composition of item 3, another suitable item, or any combination of suitable items, wherein the gas scavenger is derived from an inclusion compound. 9. An aqueous composition in which the composite is suspended as solid particles in an aqueous composition, according to item 2, other suitable items, or any combination of suitable items. 10. An aqueous composition of item 9, other suitable items, or any combination of suitable items, having a solid particle size of an average of approximately 0.5 μm to approximately 30 μm. 11. An aqueous composition of item 2, other suitable items, or any combination of suitable items, in which the composite is air-milled. 12. An aqueous composition in which the complex is solubilized, of item 2, other suitable items, or any combination of suitable items. 13. An aqueous composition of item 2, another suitable item, or any combination of suitable items, wherein the complex is present in a concentration of about 0.1% to about 50% by weight of the aqueous composition. 14. An aqueous composition of item 2, another suitable item, or any combination of suitable items, wherein the complex is present in a concentration of about 0.5% to about 30% by weight of the aqueous composition. 15. An aqueous composition of item 2, another suitable item, or any combination of suitable items, wherein the complex is present in a concentration of about 0.5% to about 20% by weight of the aqueous composition. 16. An aqueous composition of item 2, another suitable item, or any combination of suitable items, wherein the complex is present in a concentration of about 0.5% to about 10% by weight of the aqueous composition. 17.1- An aqueous composition comprising item 1, another suitable item, or any combination of suitable items, wherein MCP is contained in the solution. 18.1- An aqueous composition of item 17, other suitable items, or any combination of suitable items, wherein MCP is present in a solution at a concentration of about 0.1% to about 1.0%. 19.1- An aqueous composition of item 17, other suitable items, or any combination of suitable items, wherein MCP is present in a solution at a concentration of about 1% to about 2%. An aqueous composition of item 17, other suitable items, or any combination of suitable items, wherein 20.1-MCP is present in the solution at a concentration of about 2% to about 3%. 21.1- An aqueous composition of item 17, other suitable items, or any combination of suitable items, wherein MCP is present in a solution at a concentration of approximately 3% to approximately 4%. An aqueous composition of item 17, other suitable items, or any combination of suitable items, wherein 22.1-MCP is present in the solution at a concentration of about 4% to about 5%. 23.1- An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein MCP is present in the solution at a concentration of approximately 1%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 24.1-MCP is present in the solution at a concentration of approximately 1.1%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 25.1-MCP is present in the solution at a concentration of approximately 1.2%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 26.1-MCP is present in the solution at a concentration of approximately 1.3%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 27.1-MCP is present in the solution at a concentration of approximately 1.4%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 28.1-MCP is present in the solution at a concentration of approximately 1.5%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 29.1-MCP is present in the solution at a concentration of approximately 1.6%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 30.1-MCP is present in the solution at a concentration of approximately 1.7%. 31.1-MCP is present in the solution at a concentration of approximately 1.8% in an aqueous composition of item 17, another suitable item, or any combination of suitable items. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 32.1-MCP is present in the solution at a concentration of approximately 1.9%. 33.1- An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein MCP is present in the solution at a concentration of approximately 2%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 34.1-MCP is present in the solution at a concentration of approximately 2.1%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 35.1-MCP is present in the solution at a concentration of approximately 2.2%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 36.1-MCP is present in the solution at a concentration of approximately 2.3%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 37.1-MCP is present in the solution at a concentration of approximately 2.4%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 38.1-MCP is present in the solution at a concentration of approximately 2.5%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 39.1-MCP is present in the solution at a concentration of approximately 2.6%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 40.1-MCP is present in the solution at a concentration of approximately 2.7%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 41.1-MCP is present in the solution at a concentration of approximately 2.8%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 42.1-MCP is present in the solution at a concentration of approximately 2.9%. 43.1-MCP is present in the solution at a concentration of approximately 3% in an aqueous composition of item 17, another suitable item, or any combination of suitable items. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 44.1-MCP is present in the solution at a concentration of approximately 3.1%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 45.1-MCP is present in the solution at a concentration of approximately 3.2%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 46.1-MCP is present in the solution at a concentration of approximately 3.3%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 47.1-MCP is present in the solution at a concentration of approximately 3.4%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 48.1-MCP is present in the solution at a concentration of approximately 3.5%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 49.1-MCP is present in the solution at a concentration of approximately 3.6%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 50.1-MCP is present in the solution at a concentration of approximately 3.7%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 51.1-MCP is present in the solution at a concentration of approximately 3.8%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 52.1-MCP is present in the solution at a concentration of approximately 3.9%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 53.1-MCP is present in the solution at a concentration of approximately 4%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 54.1-MCP is present in the solution at a concentration of approximately 4.1%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 55.1-MCP is present in the solution at a concentration of approximately 4.2%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 56.1-MCP is present in the solution at a concentration of approximately 4.3%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 57.1-MCP is present in the solution at a concentration of approximately 4.4%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 58.1-MCP is present in the solution at a concentration of approximately 4.5%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 59.1-MCP is present in the solution at a concentration of approximately 4.6%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 60.1-MCP is present in the solution at a concentration of approximately 4.7%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 61.1-MCP is present in the solution at a concentration of approximately 4.8%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 62.1-MCP is present in the solution at a concentration of approximately 4.9%. An aqueous composition of item 17, another suitable item, or any combination of suitable items, wherein 63.1-MCP is present in the solution at a concentration of approximately 5%. 64.1- An aqueous composition comprising item 1, another suitable item, or any combination of suitable items, in which MCP is present in powder form. 65. An aqueous composition in which the powder is a wettable powder, according to item 64, other suitable items, or any combination of suitable items. Aqueous compositions of item 64, other suitable items, or any combination of suitable items, wherein 66.1-MCP is present in the powder at an amount of about 0.1% to about 1.0%. Aqueous compositions of item 64, other suitable items, or any combination of suitable items, wherein 67.1-MCP is present in the powder at an amount of about 1% to about 2%. Aqueous compositions of item 64, other suitable items, or any combination of suitable items, wherein 68.1-MCP is present in the powder at an amount of about 2% to about 3%. Aqueous compositions of item 64, other suitable items, or any combination of suitable items, wherein 69.1-MCP is present in the powder at an amount of about 3% to about 4%. Aqueous compositions of item 64, other suitable items, or any combination of suitable items, wherein 70.1-MCP is present in the powder at an amount of about 4% to about 5%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 71.1-MCP is present in the powder at a concentration of approximately 1%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 72.1-MCP is present in the powder at a concentration of approximately 1.1%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 73.1-MCP is present in the powder at an amount of approximately 1.2%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 74.1-MCP is present in the powder at a concentration of approximately 1.3%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 75.1-MCP is present in the powder at a concentration of approximately 1.4%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 76.1-MCP is present in the powder at a concentration of approximately 1.5%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 77.1-MCP is present in the powder at a concentration of approximately 1.6%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 78.1-MCP is present in the powder at a concentration of approximately 1.7%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 79.1-MCP is present in the powder at a concentration of approximately 1.8%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 80.1-MCP is present in the powder at a concentration of approximately 1.9%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 81.1-MCP is present in the powder at a concentration of approximately 2%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 82.1-MCP is present in the powder at a concentration of approximately 2.1%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 83.1-MCP is present in the powder at a concentration of approximately 2.2%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 84.1-MCP is present in the powder at a concentration of approximately 2.3%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 85.1-MCP is present in the powder at a concentration of approximately 2.4%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 86.1-MCP is present in the powder at a concentration of approximately 2.5%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 87.1-MCP is present in the powder at a concentration of approximately 2.6%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 88.1-MCP is present in the powder at a concentration of approximately 2.7%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 89.1-MCP is present in the powder at a concentration of approximately 2.8%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 90.1-MCP is present in the powder at a concentration of approximately 2.9%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 91.1-MCP is present in the powder at a concentration of approximately 3%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 92.1-MCP is present in the powder at a concentration of approximately 3.1%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 93.1-MCP is present in the powder at a concentration of approximately 3.2%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 94.1-MCP is present in the powder at a concentration of approximately 3.3%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 95.1-MCP is present in the powder at a concentration of approximately 3.4%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 96.1-MCP is present in the powder at a concentration of approximately 3.5%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 97.1-MCP is present in the powder at a concentration of approximately 3.6%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 98.1-MCP is present in the powder at a concentration of approximately 3.7%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 99.1-MCP is present in the powder at a concentration of approximately 3.8%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 100.1-MCP is present in the powder at a concentration of approximately 3.9%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 101.1-MCP is present in the powder at a concentration of approximately 4%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 102.1-MCP is present in the powder at a concentration of approximately 4.1%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 103.1-MCP is present in the powder at a concentration of approximately 4.2%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 104.1-MCP is present in the powder at a concentration of approximately 4.3%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 105.1-MCP is present in the powder at a concentration of approximately 4.4%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 106.1-MCP is present in the powder at a concentration of approximately 4.5%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 107.1-MCP is present in the powder at a concentration of approximately 4.6%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 108.1-MCP is present in the powder at a concentration of approximately 4.7%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 109.1-MCP is present in the powder at a concentration of approximately 4.8%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 110.1-MCP is present in the powder at a concentration of approximately 4.9%. An aqueous composition of item 64, another suitable item, or any combination of suitable items, wherein 111.1-MCP is present in the powder at a concentration of approximately 5%. 112. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieve, and any combination thereof. 113. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenging agent comprises alpha-cyclodextrin. 114. An aqueous composition comprising activated carbon (charcoal) as a gas scavenger, according to item 1, another suitable item, or any combination thereof. 115. An aqueous composition comprising activated carbon as a gas scavenger, according to item 1, another suitable item, or any combination thereof. 116. An aqueous composition comprising porous silica as a gas scavenger, according to item 1, another suitable item, or any combination of suitable items. 117. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenging agent comprises a molecular sieve. 118. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is present in an amount of about 0.1% to about 50% by weight of water in the aqueous composition. 119. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is present in an amount of about 1% to about 30% by weight of water in the aqueous composition. 120. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is present in an amount of about 2% to about 20% by weight of water in the aqueous composition. 121. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is present in an amount of about 2.5% to about 15% by weight of water in the aqueous composition. 122. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is in an amount of about 1% to about 10% by weight of water in the aqueous composition. 123. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is present in an amount of about 3% to about 10% by weight of water in the aqueous composition. 124. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 1% by weight of water in the aqueous composition. 125. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is approximately 2% by weight of water in the aqueous composition. 126. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is approximately 3% by weight of water in the aqueous composition. 127. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is approximately 4% by weight of water in the aqueous composition. 128. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 5% by weight of water in the aqueous composition. 129. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 6% by weight of water in the aqueous composition. 130. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is approximately 7% by weight of water in the aqueous composition. 131. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 8% by weight of water in the aqueous composition. 132. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 9% by weight of water in the aqueous composition. 133. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 10% by weight of water in the aqueous composition. 134. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 11% by weight of water in the aqueous composition. 135. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 12% by weight of water in the aqueous composition. 136. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 13% by weight of water in the aqueous composition. 137. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 14% by weight of water in the aqueous composition. 138. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the gas scavenger is about 15% by weight of water in the aqueous composition. 139. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the total amount of 1-MCP in the aqueous composition is maintained at at least 10% by weight of the initial amount of 1-MCP for 24 hours. 140. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the total amount of 1-MCP in the aqueous composition is maintained at at least 25% by weight of the initial amount of 1-MCP for 24 hours. 141. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the total amount of 1-MCP in the aqueous composition is maintained at at least 50% by weight of the initial amount of 1-MCP for 24 hours. 142. An aqueous composition of item 1, another suitable item, or any combination of suitable items, wherein the total amount of 1-MCP in the aqueous composition is maintained at at least 75% by weight of the initial amount of 1-MCP for 24 hours. 143. An aqueous composition of item 1, another suitable item, or any combination of suitable items, further comprising a water conditioner, a metal chelating agent, a pH adjuster, a biocide, a preservative, a surfactant, a dispersant, a wetting agent, a spray aid, a polymer, or any combination thereof. 144. An aqueous composition of item 1, another suitable item, or any combination of suitable items, further comprising a fungicide, insecticide, herbicide, fertilizer, nutrient, or any combination thereof. 145. A solid composition comprising i) 1-MCP and ii) a gas scavenger. A solid composition comprising item 145, other suitable items, or any combination of suitable items, in which 146.1-MCP is included in the complex. 147. A solid composition of item 146, other suitable items, or any combination of suitable items, wherein the complex is an inclusion compound. 148. A solid composition comprising a cyclodextrin as an inclusion compound, according to item 147, other suitable items, or any combination of suitable items. 149. A solid composition comprising an alpha-cyclodextrin as an inclusion compound, according to item 147, other suitable items, or any combination of suitable items. 150. A solid composition of item 147, other suitable items, or any combination of suitable items, wherein the inclusion compound essentially consists of alpha-cyclodextrin. 151. A solid composition comprising alpha-cyclodextrin as the inclusion compound, according to item 147, other suitable items, or any combination thereof. 152. A solid composition of item 147, other suitable items, or any combination of suitable items, wherein the gas scavenging agent is derived from an inclusion compound. 153. A solid composition in which the composite exists as solid particles in the solid composition, according to item 146, other suitable items, or any combination of suitable items. 154. A solid composition having an average solid particle size of approximately 0.5 μm to approximately 30 μm, of item 153, other suitable items, or any combination of suitable items. 155. A solid composition of item 146, other suitable items, or any combination of suitable items, wherein the composite is air-pulverized. 156. A solid composition in which the composite is about 2% to about 90% by weight of the whole composition, item 146, other suitable items, or any combination of suitable items. 157.1- A solid composition containing MCP in powder form, item 145, other suitable items, or any combination of suitable items. 158. A solid composition in which the powder is a wettable powder, according to item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 159.1-MCP is present in the powder at an amount of about 0.1% to about 1.0%. A solid composition in which 160.1-MCP is present in a powder at an amount of about 1% to about 2% of item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 161.1-MCP is present in the powder at an amount of about 2% to about 3%. A solid composition in which 162.1-MCP is present in a powder at a concentration of approximately 3% to approximately 4% of item 157, other suitable items, or any combination of suitable items. A solid composition in which 163.1-MCP is present in a powder at a concentration of approximately 4% to approximately 5% of item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 164.1-MCP is present in the powder at a concentration of approximately 1%. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 165.1-MCP is present in the powder at a concentration of approximately 1.1%. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 166.1-MCP is present in the powder at a concentration of approximately 1.2%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 167.1-MCP is present in the powder at a concentration of approximately 1.3%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 168.1-MCP is present in the powder at a concentration of approximately 1.4%. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 169.1-MCP is present in the powder at a concentration of approximately 1.5%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 170.1-MCP is present in the powder at a concentration of approximately 1.6%. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 171.1-MCP is present in the powder at a concentration of approximately 1.7%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 172.1-MCP is present in the powder at a concentration of approximately 1.8%. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 173.1-MCP is present in the powder at a concentration of approximately 1.9%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 174.1-MCP is present in the powder at a concentration of approximately 2%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 175.1-MCP is present in the powder at a concentration of approximately 2.1%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 176.1-MCP is present in the powder at an amount of approximately 2.2%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 177.1-MCP is present in the powder at a concentration of approximately 2.3%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 178.1-MCP is present in the powder at a concentration of approximately 2.4%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 179.1-MCP is present in the powder at a concentration of approximately 2.5%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 180.1-MCP is present in the powder at a concentration of approximately 2.6%. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 181.1-MCP is present in the powder at a concentration of approximately 2.7%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 182.1-MCP is present in the powder at a concentration of approximately 2.8%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 183.1-MCP is present in the powder at a concentration of approximately 2.9%. A solid composition in which 184.1-MCP is present in the powder at a concentration of approximately 3%. Item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 185.1-MCP is present in the powder at a concentration of approximately 3.1%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 186.1-MCP is present in the powder at a concentration of approximately 3.2%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 187.1-MCP is present in the powder at a concentration of approximately 3.3%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 188.1-MCP is present in the powder at a concentration of approximately 3.4%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 189.1-MCP is present in the powder at a concentration of approximately 3.5%. A solid composition in which 190.1-MCP is present in the powder at a concentration of approximately 3.6%: item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 191.1-MCP is present in the powder at an amount of approximately 3.7%. A solid composition in which 192.1-MCP is present in the powder at a concentration of approximately 3.8%: item 157, other suitable items, or any combination of suitable items. A solid composition in which 193.1-MCP is present in the powder at a concentration of approximately 3.9% of item 157, other suitable items, or any combination of suitable items. A solid composition in which 194.1-MCP is present in the powder at a concentration of approximately 4%. Item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 195.1-MCP is present in the powder at a concentration of approximately 4.1%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 196.1-MCP is present in the powder at a concentration of approximately 4.2%. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 197.1-MCP is present in the powder at a concentration of approximately 4.3%. A solid composition in which 198.1-MCP is present in the powder at a concentration of approximately 4.4% of item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 199.1-MCP is present in the powder at a concentration of approximately 4.5%. A solid composition in which 200.1-MCP is present in the powder at an amount of approximately 4.6% of item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, wherein 201.1-MCP is present in the powder at an amount of approximately 4.7%. A solid composition in which 202.1-MCP is present in the powder at a concentration of approximately 4.8% of item 157, other suitable items, or any combination of suitable items. A solid composition of item 157, another suitable item, or any combination of suitable items, in which 203.1-MCP is present in the powder at a concentration of approximately 4.9%. A solid composition in which 204.1-MCP is present in the powder at a concentration of approximately 5%. Item 157, other suitable items, or any combination of suitable items. 205. A solid composition of item 145, another suitable item, or any combination of suitable items, wherein the gas scavenger is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieve, and any combination thereof. 206. A solid composition comprising alpha-cyclodextrin as a gas scavenger, according to item 145, other suitable items, or any combination thereof. 207. A solid composition comprising activated carbon (charcoal) as a gas scavenger, according to item 145, other suitable items, or any combination thereof. 208. A solid composition comprising activated carbon as a gas scavenger, item 145, other suitable items, or any combination of suitable items. 209. A solid composition comprising porous silica as a gas scavenger, according to item 145, other suitable items, or any combination of suitable items. 210. A solid composition comprising a gas scavenger including a molecular sieve, item 145, other suitable items, or any combination of suitable items. 211. A solid composition of item 145, other suitable items, or any combination of suitable items, wherein the gas scavenger is present in an amount of about 10% to about 98% by weight of the whole composition. 212. A solid composition of item 145, another suitable item, or any combination of suitable items, wherein the aqueous composition further comprises a water conditioner, a metal chelating agent, a pH adjuster, a biocide, a preservative, a surfactant, a dispersant, a wetting agent, a spray aid, a polymer, or any combination thereof. 213. A solid composition of item 145, another suitable item, or any combination of suitable items, wherein the aqueous composition further comprises a fungicide, insecticide, herbicide, fertilizer, nutrient, or any combination thereof. 214. A solid composition which can be diluted with water to form an aqueous composition, according to item 145, other suitable items, or any combination of suitable items. 215. A method for preparing an aqueous composition, a) Add water to the container, b) Adding a gas scavenger to the container, c) The step of adding 1-MCP to the container, and d) A step of mixing water, a gas scavenger, and 1-MCP to form an aqueous composition. A method that includes this. 216. A method in which step c) is performed simultaneously with step b), using term 215, another suitable term, or any combination of suitable terms. 217. A method in which step c) is performed after step b) using term 215, another suitable term, or any combination of suitable terms. 218. A method of mixing, according to item 215, other suitable items, or any combination of suitable items, wherein the mixing is carried out until the aqueous composition is homogeneous. A method of which 219.1-MCP is included in the complex of item 215, other suitable items, or any combination of suitable items. 220. A method in which the complex is an inclusion compound, according to item 219, other suitable items, or any combination of suitable items. 221. A method comprising item 220, other suitable items, or any combination of suitable items, wherein the inclusion compound comprises a cyclodextrin. 222. A method comprising item 220, other suitable items, or any combination of suitable items, wherein the inclusion compound comprises alpha-cyclodextrin. 223. A method in which the inclusion compound essentially consists of an alpha-cyclodextrin, according to item 220, other suitable items, or any combination of suitable items. 224. A method comprising item 220, other suitable items, or any combination of suitable items, wherein the inclusion compound consists of an alpha-cyclodextrin. 225. A method in which the gas scavenger is derived from an inclusion compound, according to item 220, other suitable items, or any combination of suitable items. 226. A method, according to item 219, other suitable items, or any combination of suitable items, wherein the composite is suspended as solid particles in an aqueous composition. 227. A method in which the solid particle size is on average about 0.5 μm to about 30 μm, item 226, other suitable items, or any combination of suitable items. 228. A method by which the composite is air-pulverized, according to item 219, other suitable items, or any combination of suitable items. 229. A method of solubilizing a complex in an aqueous composition, according to item 219, other suitable items, or any combination of suitable items. 230. A method of preparing an aqueous composition in which the complex is present at a concentration of about 0.1% to about 50% by weight of item 219, other suitable items, or any combination of suitable items. 231. A method of preparing an aqueous composition in which the complex is present at a concentration of about 0.5% to about 30% by weight of item 219, other suitable items, or any combination of suitable items. 232. A method of preparing an aqueous composition in which the complex is present at a concentration of about 0.5% to about 20% by weight of item 219, other suitable items, or any combination of suitable items. 233. A method of preparing an aqueous composition in which the complex is present at a concentration of about 0.5% to about 10% by weight of item 219, other suitable items, or any combination of suitable items. 234.1 A method in which MCP is contained in a solution, according to item 215, other suitable items, or any combination of suitable items. Methods of item 234, other suitable items, or any combination of suitable items, wherein 235.1-MCP is present in the solution at a concentration of approximately 0.1% to approximately 1.0%. Methods of item 234, other suitable items, or any combination of suitable items, wherein 236.1-MCP is present in a solution at a concentration of approximately 1% to approximately 2%. Methods in which 237.1-MCP is present in a solution at a concentration of approximately 2% to 3%, such as item 234, other suitable items, or any combination of suitable items. Methods of item 234, other suitable items, or any combination of suitable items, wherein 238.1-MCP is present in a solution at a concentration of approximately 3% to 4%. Methods in which 239.1-MCP is present in a solution at a concentration of approximately 4% to 5%, such as item 234, other suitable items, or any combination of suitable items. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 240.1-MCP is present in a solution at a concentration of approximately 1%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 241.1-MCP is present in the solution at a concentration of approximately 1.1%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 242.1-MCP is present in a solution at a concentration of approximately 1.2%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 243.1-MCP is present in the solution at a concentration of approximately 1.3%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 244.1-MCP is present in the solution at a concentration of approximately 1.4%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 245.1-MCP is present in a solution at a concentration of approximately 1.5%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 246.1-MCP is present in a solution at a concentration of approximately 1.6%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 247.1-MCP is present in solution at a concentration of approximately 1.7%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 248.1-MCP is present in a solution at a concentration of approximately 1.8%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 249.1-MCP is present in the solution at a concentration of approximately 1.9%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 250.1-MCP is present in a solution at a concentration of approximately 2%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 251.1-MCP is present in the solution at a concentration of approximately 2.1%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 252.1-MCP is present in a solution at a concentration of approximately 2.2%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 253.1-MCP is present in a solution at a concentration of approximately 2.3%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 254.1-MCP is present in the solution at a concentration of approximately 2.4%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 255.1-MCP is present in a solution at a concentration of approximately 2.5%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 256.1-MCP is present in a solution at a concentration of approximately 2.6%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 257.1-MCP is present in a solution at a concentration of approximately 2.7%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 258.1-MCP is present in a solution at a concentration of approximately 2.8%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 259.1-MCP is present in the solution at a concentration of approximately 2.9%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 260.1-MCP is present in a solution at a concentration of approximately 3%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 261.1-MCP is present in the solution at a concentration of approximately 3.1%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 262.1-MCP is present in solution at a concentration of approximately 3.2%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 263.1-MCP is present in solution at a concentration of approximately 3.3%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 264.1-MCP is present in the solution at a concentration of approximately 3.4%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 265.1-MCP is present in the solution at a concentration of approximately 3.5%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 266.1-MCP is present in the solution at a concentration of approximately 3.6%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 267.1-MCP is present in the solution at a concentration of approximately 3.7%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 268.1-MCP is present in a solution at a concentration of approximately 3.8%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 269.1-MCP is present in a solution at a concentration of approximately 3.9%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 270.1-MCP is present in a solution at a concentration of approximately 4%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 271.1-MCP is present in the solution at a concentration of approximately 4.1%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 272.1-MCP is present in the solution at a concentration of approximately 4.2%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 273.1-MCP is present in the solution at a concentration of approximately 4.3%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 274.1-MCP is present in the solution at a concentration of approximately 4.4%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 275.1-MCP is present in the solution at a concentration of approximately 4.5%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 276.1-MCP is present in the solution at a concentration of approximately 4.6%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 277.1-MCP is present in the solution at a concentration of approximately 4.7%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 278.1-MCP is present in a solution at a concentration of approximately 4.8%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 279.1-MCP is present in a solution at a concentration of approximately 4.9%. A method comprising item 234, another suitable item, or any combination of suitable items, wherein 280.1-MCP is present in a solution at a concentration of approximately 5%. 281.1- A method of incorporating MCP into a powder, according to item 215, other suitable items, or any combination of suitable items. 282. A method in which the powder is a wettable powder, according to item 281, another suitable item, or any combination of suitable items. 283.1- A method in which MCP is present in the powder at an amount of approximately 0.1% to approximately 1.0%, such as item 281, other suitable items, or any combination of suitable items. 284.1- A method in which MCP is present in the powder at an amount of approximately 1% to approximately 2%, such as item 281, other suitable items, or any combination of suitable items. 285.1- A method in which MCP is present in the powder at a concentration of approximately 2% to 3%, as specified in item 281, other suitable items, or any combination of suitable items. 286.1- A method in which MCP is present in the powder at a concentration of approximately 3% to 4%, as specified in item 281, other suitable items, or any combination of suitable items. 287.1- A method in which MCP is present in the powder at a concentration of approximately 4% to 5%, as specified in item 281, other suitable items, or any combination of suitable items. 288.1- A method in which MCP is present in the powder at a concentration of approximately 1%, according to item 281, other suitable items, or any combination of suitable items. 289.1- A method in which MCP is present in the powder at a concentration of approximately 1.1%, using item 281, another suitable item, or any combination of suitable items. 290.1- A method in which MCP is present in the powder at a concentration of approximately 1.2%, using item 281, other suitable items, or any combination of suitable items. 291.1- A method in which MCP is present in the powder at a concentration of approximately 1.3% of item 281, another suitable item, or any combination of suitable items. 292.1- A method in which MCP is present in the powder at a concentration of approximately 1.4% in item 281, another suitable item, or any combination of suitable items. 293.1- A method in which MCP is present in the powder at a concentration of approximately 1.5%, using item 281, other suitable items, or any combination of suitable items. 294.1- A method in which MCP is present in the powder at a concentration of approximately 1.6%, such as item 281, another suitable item, or any combination of suitable items. 295.1- A method in which MCP is present in the powder at a concentration of approximately 1.7%, such as item 281, other suitable items, or any combination of suitable items. 296.1- A method in which MCP is present in the powder at a concentration of approximately 1.8% by item 281, other suitable items, or any combination of suitable items. 297.1- A method in which MCP is present in the powder at a concentration of approximately 1.9% by item 281, another suitable item, or any combination of suitable items. 298.1- A method in which MCP is present in the powder at a concentration of approximately 2%, according to item 281, other suitable items, or any combination of suitable items. 299.1- A method in which MCP is present in the powder at a concentration of approximately 2.1% by item 281, other suitable items, or any combination of suitable items. Methods in which 300.1-MCP is present in the powder at a concentration of approximately 2.2%, such as item 281, other suitable items, or any combination of suitable items. 301.1- A method in which MCP is present in the powder at a concentration of approximately 2.3% in item 281, another suitable item, or any combination of suitable items. 302.1- A method in which MCP is present in the powder at a concentration of approximately 2.4%, using item 281, other suitable items, or any combination of suitable items. 303.1- A method in which MCP is present in the powder at a concentration of approximately 2.5%, according to item 281, other suitable items, or any combination of suitable items. 304.1- A method in which MCP is present in the powder at a concentration of approximately 2.6% in item 281, another suitable item, or any combination of suitable items. 305.1- A method in which MCP is present in the powder at a concentration of approximately 2.7%, using item 281, other suitable items, or any combination of suitable items. 306.1- A method in which MCP is present in the powder at a concentration of approximately 2.8% by item 281, other suitable items, or any combination of suitable items. 307.1- A method in which MCP is present in the powder at a concentration of approximately 2.9% by item 281, other suitable items, or any combination of suitable items. 308.1- A method in which MCP is present in the powder at a concentration of approximately 3%, according to item 281, other suitable items, or any combination of suitable items. 309.1- A method in which MCP is present in the powder at a concentration of approximately 3.1% by item 281, other suitable items, or any combination of suitable items. 310.1- A method in which MCP is present in the powder at a concentration of approximately 3.2%, using item 281, other suitable items, or any combination of suitable items. 311.1- A method in which MCP is present in the powder at a concentration of approximately 3.3%, using item 281, other suitable items, or any combination of suitable items. 312.1- A method in which MCP is present in the powder at a concentration of approximately 3.4%, using item 281, other suitable items, or any combination of suitable items. 313.1- A method in which MCP is present in the powder at a concentration of approximately 3.5%, using item 281, other suitable items, or any combination of suitable items. 314.1- A method in which MCP is present in the powder at a concentration of approximately 3.6%, using item 281, other suitable items, or any combination of suitable items. 315.1- A method in which MCP is present in the powder at a concentration of approximately 3.7%, using item 281, other suitable items, or any combination of suitable items. 316.1- A method in which MCP is present in the powder at a concentration of approximately 3.8% by item 281, other suitable items, or any combination of suitable items. 317.1- A method in which MCP is present in the powder at a concentration of approximately 3.9% in item 281, another suitable item, or any combination of suitable items. 318.1- A method in which MCP is present in the powder at a concentration of approximately 4%, such as item 281, another suitable item, or any combination of suitable items. 319.1- A method in which MCP is present in the powder at a concentration of approximately 4.1% of item 281, other suitable items, or any combination of suitable items. Methods in which 320.1-MCP is present in the powder at a concentration of approximately 4.2%, such as item 281, other suitable items, or any combination of suitable items. 321.1- A method in which MCP is present in the powder at a concentration of approximately 4.3%, using item 281, other suitable items, or any combination of suitable items. 322.1- A method in which MCP is present in the powder at a concentration of approximately 4.4% in item 281, another suitable item, or any combination of suitable items. 323.1- A method in which MCP is present in the powder at a concentration of approximately 4.5%, using item 281, other suitable items, or any combination of suitable items. 324.1- A method in which MCP is present in the powder at a concentration of approximately 4.6% in item 281, another suitable item, or any combination of suitable items. 325.1- A method in which MCP is present in the powder at a concentration of approximately 4.7%, using item 281, other suitable items, or any combination of suitable items. 326.1- A method in which MCP is present in the powder at a concentration of approximately 4.8% by item 281, other suitable items, or any combination of suitable items. 327.1- A method in which MCP is present in the powder at a concentration of approximately 4.9% by item 281, other suitable items, or any combination of suitable items. 328.1- A method in which MCP is present in the powder at a concentration of approximately 5%, according to item 281, other suitable items, or any combination of suitable items. 329. A method of item 215, another suitable item, or any combination of suitable items, wherein the gas scavenger is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieves, and any combination thereof. 330. A method comprising alphacyclodextrin as a gas scavenger, according to item 215, other suitable items, or any combination thereof. 331. A method comprising activated carbon (charcoal) as a gas scavenger, as specified in item 215, other suitable items, or any combination thereof. 332. A method comprising activated carbon as a gas scavenger, as specified in item 215, other suitable items, or any combination of suitable items. 333. A method comprising porous silica as a gas scavenger, according to item 215, other suitable items, or any combination thereof. 334. A method comprising a gas scavenger including a molecular sieve, according to item 215, other suitable items, or any combination thereof. 335. A method of which the gas scavenger is in an aqueous composition of about 0.1% to about 50% by weight of water, according to item 215, other suitable items, or any combination of suitable items. 336. A method of which the gas scavenger is about 1% to about 30% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 337. A method of which the gas scavenger is about 2% to about 20% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 338. A method of which the gas scavenger is about 2.5% to about 15% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 339. A method of which the gas scavenger is about 1% to about 10% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 340. A method in which the gas scavenger is about 3% to about 10% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 341. A method in which the gas scavenger is about 1% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 342. A method in which the gas scavenger is about 2% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 343. A method in which the gas scavenger is about 3% by weight of water in an aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 344. A method in which the gas scavenger is about 4% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 345. A method in which the gas scavenger is about 5% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 346. A method in which the gas scavenger is about 6% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 347. A method in which the gas scavenger is about 7% by weight of water in an aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 348. A method in which the gas scavenger is about 8% by weight of water in an aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 349. A method in which the gas scavenger is about 9% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 350. A method in which the gas scavenger is about 10% by weight of water in an aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 351. A method in which the gas scavenger is about 11% by weight of water in an aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 352. A method in which the gas scavenger is about 12% by weight of water in an aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 353. A method in which the gas scavenger is about 13% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 354. A method in which the gas scavenger is about 14% by weight of water in the aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 355. A method in which the gas scavenger is about 15% by weight of water in an aqueous composition, according to item 215, other suitable items, or any combination of suitable items. 356. A method of aqueous composition comprising a water conditioner, a metal chelating agent, a pH adjuster, a biocide, a preservative, a surfactant, a dispersant, a wetting agent, a spray aid, a polymer, or any combination thereof, as specified in item 215, other suitable items, or any combination thereof. 357. A method of aqueous composition further comprising a fungicide, insecticide, herbicide, fertilizer, nutrient, or any combination thereof, according to item 215, other suitable items, or any combination thereof. 358. A method for preparing a solid composition, a) A step of adding a gas scavenger to the container, b) The step of adding 1-MCP to the container, c) A step of mixing the gas scavenger and 1-MCP to form a solid composition. Methods that include... 359. A method of mixing, in which the mixing is carried out until the solid composition is homogeneous, as specified in item 358, other suitable items, or any combination of suitable items. A method of which 360.1-MCP is included in the complex in item 358, other suitable items, or any combination of suitable items. 361. A method in which the complex is an inclusion compound, according to item 360, other suitable items, or any combination of suitable items. 362. A method comprising the inclusion compound comprising a cyclodextrin, according to item 361, other suitable items, or any combination thereof. 363. A method comprising the inclusion compound comprising alpha-cyclodextrin, according to item 361, other suitable items, or any combination thereof. 364. A method wherein the inclusion compound essentially consists of an alpha-cyclodextrin, according to item 361, other suitable items, or any combination of suitable items. 365. A method comprising item 361, other suitable items, or any combination of suitable items, wherein the inclusion compound consists of an alpha-cyclodextrin. 366. A method in which the gas scavenger is derived from an inclusion compound, according to item 361, other suitable items, or any combination of suitable items. 367. A method, according to item 360, other suitable items, or any combination of suitable items, wherein the composite exists as solid particles in a solid composition. 368. A method in which the solid particle size is approximately 0.5 μm to approximately 30 μm on average, such as item 367, another suitable item, or any combination of suitable items. 369. A method by which the composite is air-pulverized, according to item 360, other suitable items, or any combination of suitable items. 370. A method of which the composite is about 2% by weight to about 90% by weight of the whole composition, according to item 360, other suitable items, or any combination of suitable items. 371.1- A method of incorporating MCP into a powder, according to item 358, other suitable items, or any combination of suitable items. 372. A method in which the powder is a wettable powder, according to item 371, other suitable items, or any combination of suitable items. 373.1- A method in which MCP is present in the powder at an amount of approximately 0.1% to approximately 1.0%, such as item 371, other suitable items, or any combination of suitable items. 374.1- A method in which MCP is present in the powder at an amount of approximately 1% to approximately 2%, as specified in item 371, other suitable items, or any combination of suitable items. 375.1- A method in which MCP is present in the powder at a concentration of approximately 2% to approximately 3%, as specified in item 371, other suitable items, or any combination of suitable items. 376.1- A method in which MCP is present in the powder at a concentration of approximately 3% to 4%, as specified in item 371, other suitable items, or any combination of suitable items. 377.1- A method in which MCP is present in the powder at a concentration of approximately 4% to 5%, as specified in item 371, other suitable items, or any combination of suitable items. 378.1- A method in which MCP is present in the powder at a concentration of approximately 1%, according to item 371, other suitable items, or any combination of suitable items. 379.1- A method in which MCP is present in the powder at a concentration of approximately 1.1%, using item 371, another suitable item, or any combination of suitable items. Methods comprising item 371, other suitable items, or any combination of suitable items, wherein 380.1-MCP is present in the powder at a concentration of approximately 1.2%. 381.1- A method in which MCP is present in the powder at a concentration of approximately 1.3% of item 371, another suitable item, or any combination of suitable items. 382.1- A method in which MCP is present in the powder at a concentration of approximately 1.4%, using item 371, other suitable items, or any combination of suitable items. 383.1- A method in which MCP is present in the powder at a concentration of approximately 1.5%, according to item 371, other suitable items, or any combination of suitable items. 384.1- A method in which MCP is present in the powder at a concentration of approximately 1.6%, using item 371, other suitable items, or any combination of suitable items. 385.1- A method in which MCP is present in the powder at a concentration of approximately 1.7%, using item 371, other suitable items, or any combination of suitable items. 386.1- A method in which MCP is present in the powder at a concentration of approximately 1.8%, using item 371, other suitable items, or any combination of suitable items. 387.1- A method in which MCP is present in the powder at a concentration of approximately 1.9% of item 371, another suitable item, or any combination of suitable items. 388.1- A method in which MCP is present in the powder at a concentration of approximately 2%, according to item 371, other suitable items, or any combination of suitable items. 389.1- A method in which MCP is present in the powder at a concentration of approximately 2.1%, using item 371, other suitable items, or any combination of suitable items. 390.1- A method in which MCP is present in the powder at a concentration of approximately 2.2%, using item 371, other suitable items, or any combination of suitable items. 391.1- A method in which MCP is present in the powder at a concentration of approximately 2.3% by item 371, other suitable items, or any combination of suitable items. 392.1- A method in which MCP is present in the powder at a concentration of approximately 2.4% of item 371, other suitable items, or any combination of suitable items. 393.1- A method in which MCP is present in the powder at a concentration of approximately 2.5%, according to item 371, other suitable items, or any combination of suitable items. 394.1- A method in which MCP is present in the powder at a concentration of approximately 2.6%, using item 371, other suitable items, or any combination of suitable items. 395.1- A method in which MCP is present in the powder at a concentration of approximately 2.7%, using item 371, other suitable items, or any combination of suitable items. 396.1- A method in which MCP is present in the powder at a concentration of approximately 2.8%, using item 371, other suitable items, or any combination of suitable items. 397.1- A method in which MCP is present in the powder at a concentration of approximately 2.9%, using item 371, other suitable items, or any combination of suitable items. 398.1- A method in which MCP is present in the powder at a concentration of approximately 3%, according to item 371, other suitable items, or any combination of suitable items. 399.1- A method in which MCP is present in the powder at a concentration of approximately 3.1%, using item 371, other suitable items, or any combination of suitable items. A method comprising item 371, another suitable item, or any combination of suitable items, wherein 400.1-MCP is present in the powder at a concentration of approximately 3.2%. Methods in which 401.1-MCP is present in the powder at a concentration of approximately 3.3%, such as item 371, other suitable items, or any combination of suitable items. Methods in which 402.1-MCP is present in the powder at a concentration of approximately 3.4%, such as item 371, other suitable items, or any combination of suitable items. 403.1- A method in which MCP is present in the powder at a concentration of approximately 3.5%, using item 371, other suitable items, or any combination of suitable items. 404.1- A method in which MCP is present in the powder at a concentration of approximately 3.6% by item 371, other suitable items, or any combination of suitable items. 405.1- A method in which MCP is present in the powder at a concentration of approximately 3.7%, using item 371, other suitable items, or any combination of suitable items. 406.1- A method in which MCP is present in the powder at a concentration of approximately 3.8%, using item 371, other suitable items, or any combination of suitable items. Methods in which 407.1-MCP is present in the powder at a concentration of approximately 3.9%, such as item 371, other suitable items, or any combination of suitable items. 408.1- A method in which MCP is present in the powder at a concentration of approximately 4%, such as item 371, other suitable items, or any combination of suitable items. Methods comprising item 371, other suitable items, or any combination of suitable items, wherein 409.1-MCP is present in the powder at a concentration of approximately 4.1%. 410.1- A method in which MCP is present in the powder at a concentration of approximately 4.2%, using item 371, other suitable items, or any combination of suitable items. 411.1- A method in which MCP is present in the powder at a concentration of approximately 4.3%, using item 371, other suitable items, or any combination of suitable items. 412.1- A method in which MCP is present in the powder at a concentration of approximately 4.4%, using item 371, other suitable items, or any combination of suitable items. 413.1- A method in which MCP is present in the powder at a concentration of approximately 4.5%, using item 371, other suitable items, or any combination of suitable items. 414.1- A method in which MCP is present in the powder at a concentration of approximately 4.6% by item 371, other suitable items, or any combination of suitable items. 415.1- A method in which MCP is present in the powder at a concentration of approximately 4.7%, using item 371, other suitable items, or any combination of suitable items. 416.1- A method in which MCP is present in the powder at a concentration of approximately 4.8%, using item 371, other suitable items, or any combination of suitable items. 417.1- A method in which MCP is present in the powder at a concentration of approximately 4.9% by item 371, other suitable items, or any combination of suitable items. 418.1- A method in which MCP is present in the powder at a concentration of approximately 5%, such as item 371, another suitable item, or any combination of suitable items. 419. A method of item 358, another suitable item, or any combination of suitable items, wherein the gas scavenger is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieves, and any combination thereof. 420. A method comprising alphacyclodextrin as a gas scavenger, according to item 358, other suitable items, or any combination thereof. 421. A method comprising activated carbon (charcoal) as a gas scavenger, as specified in item 358, other suitable items, or any combination of suitable items. 422. A method comprising activated carbon as a gas scavenger, as specified in item 358, other suitable items, or any combination of suitable items. 423. A method comprising porous silica as a gas scavenger, according to item 358, other suitable items, or any combination thereof. 424. A method comprising a gas scavenger including a molecular sieve, according to item 358, other suitable items, or any combination thereof. 425. A method in which the gas scavenger is about 10% to about 98% by weight of the whole composition, according to item 358, other suitable items, or any combination of suitable items. 426. A method of a solid composition further comprising a water conditioner, a metal chelating agent, a pH adjuster, a biocide, a preservative, a surfactant, a dispersant, a wetting agent, a spray aid, a polymer, or any combination thereof, as specified in item 358, other suitable items, or any combination thereof. 427. A method of a solid composition further comprising a fungicide, insecticide, herbicide, fertilizer, nutrient, or any combination thereof, according to item 358, another suitable item, or any combination thereof. 428. A method in which the solid composition is a granular mixture, according to item 358, other suitable items, or any combination of suitable items. 429. A method in which the solid composition is a powder mixture, according to item 358, other suitable items, or any combination of suitable items. 430. A method for granulating a powder mixture, according to item 429, other suitable items, or any combination of suitable items. 431. A method for applying an aqueous composition to a plant or plant part, comprising the step of administering the aqueous composition to the plant or plant part via an agricultural tool. 432. A method of which agricultural machinery includes a ground spraying device, as specified in item 431, other appropriate items, or any combination of appropriate items. 433. A method of which agricultural machinery includes an aerial spraying device, as specified in item 431, other suitable items, or any combination of suitable items. 434. A method by which agricultural machinery includes a drone spraying device, as specified in item 431, other appropriate items, or any combination thereof. 435. A method of agricultural machinery including a backpack sprayer, as specified in item 431, other suitable items, or any combination of suitable items. 436. A method of which agricultural equipment includes a spray tank or container, as specified in item 431, other appropriate items, or any combination thereof. 437. A method by which a spray tank or container is ventilated, according to item 436, other suitable items, or any combination thereof. 438. A method for preparing an aqueous composition in situ, according to item 431, other suitable items, or any combination thereof. 439. A method of which the aqueous composition is an aqueous composition as described in any one of the items 1 to 144, as described in item 431, another suitable item, or any combination of suitable items. 440. A method for preparing an aqueous composition according to any one of items 215 to 357, according to item 431, other suitable items, or any combination of suitable items. [Examples]
[0063] (Example 1) 1-MCP analysis in various compositions In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0064] In this example, the following procedure was followed. 1. By adding an appropriate amount of a-CD to water and dissolving it, aqueous a-CD stock solutions of various concentrations were prepared. 2.1-MCP preparation (also known as AF-701) was weighed into approximately 122 ml of serum vial. 3. The α-CD stock solution was weighed into a bottle, and then the bottle was immediately sealed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space and liquid phase were analyzed for 1-MCP by GC-FID at various time points.
[0065] The following results were obtained for this embodiment. [Table 1] (Example 2) 1-MCP analysis in various compositions
[0066] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0067] In this example, the following procedure was followed. 1.1-MCP preparation (also known as AF-701) was weighed into approximately 250 ml bottles. 2. An appropriate amount of water was added to the bottle, and then the bottle was immediately sealed with the gas sample collection cap. 3. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space was analyzed for 1-MCP by GC-FID at various time points.
[0068] The following results were obtained for this embodiment. [Table 2] (Example 3) 1-MCP analysis in various compositions
[0069] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0070] In this example, the following procedure was followed. 1. A 10% by weight aqueous solution of a-CD was prepared by adding an appropriate amount of a-CD to water and dissolving it. 2.1-MCP preparation (also known as AF-701) was weighed into approximately 122 ml of serum vial. 3. The α-CD stock solution was weighed into a bottle, and then the bottle was immediately sealed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space and liquid phase were analyzed for 1-MCP by GC-FID at various time points.
[0071] The following results were obtained for this embodiment. [Table 3] (Example 4) 1-MCP analysis in various compositions
[0072] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0073] In this example, the following procedure was followed. 1. A 10% by weight aqueous solution of a-CD was prepared by adding an appropriate amount of a-CD to water and dissolving it. 2.1-MCP preparation (also known as AF-701) was weighed into approximately 122 ml of serum vial. 3. The α-CD stock solution was weighed into a bottle, and then the bottle was immediately sealed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space and liquid phase were analyzed for 1-MCP by GC-FID at various time points.
[0074] The following results were obtained for this example, showing the 1-MCP retention percentage over time, using 10% α-CD(aq) at a spray volume of 200 L / acre. [Table 4] (Example 5) 1-MCP analysis in various compositions
[0075] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0076] In this example, the following procedure was followed. 1. Weigh approximately 135 ml of a-CD solid into a Wheaton bottle. 2. The HAIP (High-Aerosol Pulverization) was weighed into a bottle. 3. Tetrasodium EDTA was weighed into a bottle. 4. The water was heated to 40°C, then an appropriate amount was added to the bottle, and the bottle was immediately sealed with the gas sample collection cap. 5. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space was analyzed for 1-MCP by GC-FID at various time points.
[0077] The following results were obtained for this embodiment. [Table 5] [Table 6] (Example 6) 1-MCP analysis in various compositions
[0078] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0079] In this example, the following procedure was followed. 1. By adding appropriate amounts of materials to water, aqueous stock solutions of candidate gas containment agents of various concentrations were prepared. 2. The solid HAIP was weighed into approximately 122 ml serum bottles. 3. The stock solution was weighed into a bottle, and then the bottle was immediately sealed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space was analyzed for 1-MCP by GC-FID at various time points.
[0080] The following results were obtained for this embodiment. [Table 7] (Example 7) 1-MCP analysis in various compositions
[0081] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0082] In this example, the following procedure was followed. 1. An aqueous stock solution saturated with alpha-cyclodextrin was prepared at 40°C by adding an excess amount of alpha-cyclodextrin until solid precipitate was visible. 2. Approximately 135 ml of air-pulverized HAIP was weighed into a Wheaton jar. 3. An appropriate amount of the stock solution was added to the bottle at 40°C, and then the bottle was immediately sealed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space was analyzed for 1-MCP by GC-FID at various time points.
[0083] The following results were obtained for this embodiment. [Table 8] (Example 8) 1-MCP analysis in various compositions
[0084] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0085] In this example, the following procedure was followed. 1. Approximately 135 ml of air-pulverized HAIP was weighed into a Wheaton jar. 2. Alpha-cyclodextrin was weighed into a bottle. 3. An appropriate amount of 40°C water was added to the bottle, and then the bottle was immediately sealed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space was analyzed for 1-MCP by GC-FID at various time points.
[0086] The following results were obtained for this embodiment. [Table 9] (Example 9) 1-MCP analysis in various compositions
[0087] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0088] In this example, the following procedure was followed. 1. 3g of air-pulverized HAIP was weighed into approximately 135ml of Wheaton jar. 2. 3g of alpha-cyclodextrin was weighed into a bottle. 3. 54 ml of 40°C water was added to the bottle, and then the bottle was immediately closed with the vented gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space and liquid phase were analyzed for 1-MCP by GC-FID at various time points.
[0089] The following results were obtained for this embodiment. [Table 10] (Example 10) 1-MCP analysis in various compositions
[0090] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0091] In this example, the following procedure was followed. 1. An aqueous stock solution saturated with either food-grade or industrial-grade alphacyclodextrin was prepared at 40°C by adding an excess amount of alphacyclodextrin until solid precipitate was visible. 2. Approximately 135 ml of air-pulverized HAIP was weighed into a Wheaton jar. 3. An appropriate amount of the stock solution was added to the bottle at 40°C, and then the bottle was immediately sealed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space was analyzed for 1-MCP by GC-FID at various time points.
[0092] The following results were obtained for this embodiment. [Table 11] (Example 11) 1-MCP analysis in various compositions
[0093] In this example, the following materials can be used: Harvista™ (AF-701) containing 1.21% 1-MCP, 1-MCP / alphacyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alphacyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-ground HAIP containing 4.29% 1-MCP.
[0094] For sample #1, the following procedure was followed. 1. 2g of air-pulverized HAIP was weighed into approximately 135ml of Wheaton jar. 2. 4g of alpha-cyclodextrin was weighed into a bottle. 3. 54 ml of 40°C water was added to the bottle, and then the bottle was immediately closed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space was analyzed for 1-MCP by GC-FID at various time points.
[0095] For sample #2, the following procedure was followed. 1. An aqueous stock solution was prepared by mixing 4 g of alpha-cyclodextrin with 54 ml of water. 2. Approximately 135 ml of air-pulverized HAIP was weighed into a Wheaton jar. 3. The stock solution was heated to 40 °C, added to the bottle, and then the bottle was immediately sealed with a gas sampling lid. 4. The bottle was placed on a horizontal orbital shaker throughout the experiment, and the headspace was analyzed for 1-MCP by GC-FID at various time points.
[0096] The 1-MCP concentration in the headspace after 1 hour was measured to be 8168 ppm v / v for sample #1 and 8080 ppm v / v for sample #2. (Example 12) 1-MCP analysis in various compositions
[0097] In this example, the following materials can be used: Harvista (trademark) (AF-701) containing 1.21% 1-MCP, 1-MCP / alpha-cyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alpha-cyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-milled HAIP containing 4.29% 1-MCP.
[0098] In this example, the following procedure was followed. 1. Air-milled HAIP was weighed into a ~135 ml Wheaton bottle. 2. The selected cyclodextrin was weighed into the bottle. 3. 54 ml of water equilibrated at the selected temperature was added to the bottle, and then the bottle was immediately sealed with a gas sampling lid. 4. The bottle was placed on a horizontal orbital shaker throughout the experiment, and the headspace was analyzed for 1-MCP by GC-FID at various time points.
[0099] The following results were obtained for this example.
Table 12
[0100] In this example, the following materials can be used: Harvista (trademark) (AF-701) containing 1.21% 1-MCP, 1-MCP / alpha-cyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alpha-cyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-milled HAIP containing 4.29% 1-MCP.
[0101] In this example, the following procedure was followed. 1. A 5 wt% aqueous stock solution of food-grade alpha-cyclodextrin was prepared by mixing 5 parts by weight of alpha-cyclodextrin with 95 parts by weight of water until completely dissolved. 2. The selected 1-MCP product was weighed into a ~122 ml serum bottle. 3. An appropriate amount of the 5% stock solution was added to the bottle, and then the bottle was immediately sealed with a gas sampling cap. 4. Throughout the experiment, the bottle was placed on a horizontal orbital shaker, and the headspace was analyzed for 1-MCP at various time points by GC-FID.
[0102] The following results were obtained for this example.
Table 13
[0103] In this example, the following materials can be used: Harvista (trademark) (AF-701) containing 1.21% 1-MCP, 1-MCP / alpha-cyclodextrin complex (HAIP) containing 4.68% 1-MCP, 1-MCP / alpha-cyclodextrin complex (AFxRD-038) containing 4.05% 1-MCP, and air-milled HAIP containing 4.29% 1-MCP.
[0104] In this example, the following procedure was followed. 1. A solid mixed composition was prepared by thoroughly mixing appropriate amounts of each solid component. 2. Approximately 6 g of the solid mixture was weighed into approximately 135 ml of Wheaton jar. 3. 60 ml of water was added to the bottle, and then the bottle was immediately closed with the gas sample collection cap. 4. Throughout the experiment, the bottles were placed on a horizontal orbital shaker, and the upper space was analyzed for 1-MCP by GC-FID at various time points.
[0105] The following results were obtained for this embodiment. [Table 14] (Example 15) Stability analysis of 1-MCP-containing aqueous compositions using gas containment agents.
[0106] This example evaluated the stability of various 1-methylcyclopropene (1-MCP)-containing aqueous compositions in and without a gas containment agent. The 1-MCP generated in the upper space was analyzed, and the remainder in the solution was calculated by mathematical subtraction. Considering its explosive limits (e.g., 13,000 to 103,000 ppm), a 10,000 ppm upper limit was used for 1-MCP in the upper space.
[0107] The 1-MCP analysis method is based on a comparison between the upper space concentration and an external cis-2-butene standard (9878 ppm, produced by diluting 99.30% cis-2-butene). The materials used in this example are as follows: [Table 15]
[0108] The stock solution of the 1-MCP-containing composition (e.g., AF-701) was shaken before use to ensure homogeneity. The stock solution was left on a reciprocating shaker for at least 30 minutes, followed by visual inspection to confirm that the 1-MCP-containing composition was thoroughly mixed.
[0109] The 1-MCP-containing composition (e.g., AF-701) was weighed into a 250 ml Boston round bottle. A specified amount of gas encapsulant (e.g., 5% α-cyclodextrin) was added, and then the resulting aqueous composition was immediately sealed with a gas sample lid. The sample bottle was placed on a horizontal orbital shaker, and the headspace of the bottle was analyzed for 1-MCP at various time points by GC-FID. Test aqueous composition sample [Table 16] 1-MCP concentration (ppm) in the headspace of the aqueous composition [Table 17] % of 1-MCP remaining in the solution of the aqueous composition [Table 18]
[0110] The inclusion of the gas encapsulant demonstrated improved safety of the aqueous 1-MCP-containing composition. As shown in Figure 1, the amount of 1-MCP in the headspace rapidly increases into the explosive range when the gas encapsulant is not utilized.
[0111] Figure 2 shows that without the gas encapsulant, an amount of 1-MCP necessary for effective treatment (e.g., 80% remaining in solution) is not present in the aqueous composition. In other words, the inclusion of the gas encapsulant provides a sufficient amount of 1-MCP for effective treatment. (Example 16) Further analysis of the stability of 1-MCP-containing aqueous compositions using a gas encapsulant
[0112] This example further evaluated the stability of various 1-MCP-containing aqueous compositions containing a gas encapsulant. In particular, the stability was measured at high temperature. Analysis of the 1-MCP generated in the headspace was performed, and mathematical subtraction was carried out to calculate the remainder in the solution. Considering its explosion limit (e.g., 13000 to 103000 ppm), an upper limit of 10000 ppm was utilized for 1-MCP in the headspace.
[0113] The 1-MCP analysis method is based on a comparison between the upper space concentration and an external cis-2-butene standard (9878 ppm, produced by diluting 99.30% cis-2-butene). The materials used in this example are as follows: [Table 19]
[0114] The stock solution of the 1-MCP-containing composition (e.g., AF-701) was shaken before use to ensure homogeneity. The stock solution was left on a reciprocating shaker for at least 30 minutes, followed by visual inspection to confirm that the 1-MCP-containing composition was thoroughly mixed.
[0115] A 1-MCP-containing composition (e.g., AF-701) was weighed into a 250 ml Boston round vial. A gas containment agent (e.g., 5% α-cyclodextrin) was heated to 45°C and then added to the 1-MCP-containing composition. The resulting aqueous composition was immediately sealed with a gas sample lid. The sample vial was placed on a horizontal orbital shaker in a constant temperature incubator set to 45°C, and the upper space of the vial was analyzed for 1-MCP at various time points by GC-FID. Tested aqueous composition samples [Table 20] 1-MCP concentration (ppm) in the upper space of the aqueous composition [Table 21] 1-MCP% remaining in the aqueous composition solution [Table 22]
[0116] The inclusion of a gas containment agent demonstrated improved safety of the aqueous 1-MCP-containing composition. As shown in Figure 3, the amount of 1-MCP in the upper space remained below the explosive range for the aqueous 1-MCP-containing composition containing 800 L / ha. For the more concentrated aqueous 1-MCP-containing composition containing a 200 L / ha diluent, the amount of 1-MCP in the upper space was shown to be within the explosive range. After 5.5 hours, the addition of 5% gas containment agent to the aqueous composition maintained the 1-MCP content in the aqueous composition at approximately 70% for both dilution compositions. (Example 17) Further analysis of the stability of 1-MCP-containing aqueous compositions using gas containment agents.
[0117] This example further evaluated the stability of various 1-MCP-containing aqueous compositions, including gas containment agents. In particular, stability was measured at a high temperature of approximately 80°F. The 1-MCP generated in the upper space was analyzed, and the remainder in the solution was calculated by mathematical subtraction. Considering its explosive limits (e.g., 13,000 to 103,000 ppm), an upper limit of 10,000 ppm was used for 1-MCP in the upper space.
[0118] The 1-MCP analysis method is based on a comparison between the upper space concentration and an external cis-2-butene standard (9878 ppm, produced by diluting 99.30% cis-2-butene). The materials used in this example are as follows: [Table 23]
[0119] The stock solution of the 1-MCP-containing composition (e.g., AF-701) was shaken before use to ensure homogeneity. The stock solution was left on a reciprocating shaker for at least 30 minutes, followed by visual inspection to confirm that the 1-MCP-containing composition was thoroughly mixed.
[0120] A 1-MCP-containing composition (e.g., AF-701) was weighed into a 250 ml Boston round vial. A gas containment agent (e.g., 5% α-cyclodextrin) was heated to 28°C and then added to the 1-MCP-containing composition. The resulting aqueous composition was immediately sealed with a gas sample lid. The sample vial was placed on a horizontal orbital shaker in a constant temperature incubator set to 45°C, and the upper space of the vial was analyzed for 1-MCP at various time points by GC-FID. A temperature monitoring system recorded the mean temperature as 28.36°C (i.e., 83.05°F, close to the expected ambient temperature). Three separate tests were performed to collect data at different time points.
[0121] At each endpoint, a sample (approximately 3 ml) of each aqueous composition was analyzed for 1-MCP by GC / FID, comparing it to a 150 μl internal standard of 99.30% cis-2-butene. Tested aqueous composition samples [Table 24] 1-MCP recovery [Table 25] 1 = 1-MCP% determined by subtracting the 1-MCP in the upper space from the initial amount of 1-MCP. 2 = 1-MCP% determined by GC / FID analysis of the solution sample
[0122] At approximately 28°C, the inclusion of a gas containment agent demonstrated improved safety of the aqueous 1-MCP-containing composition. The gas containment agent maintained the upper space below the explosive range at 4, 7.5, and 16 hours for aqueous 1-MCP-containing compositions containing 200 L / ha and 800 L / ha.
[0123] The addition of a 5% gas containment agent to an aqueous 1-MCP-containing composition was also shown to retain a significant portion of the 1-MCP in the solution at both dilution ratios. (Example 18) Administration of aqueous composition to apple trees
[0124] This example evaluated the effectiveness of various 1-MCP-containing aqueous compositions, including a gas containment agent. Four 1-MCP-containing aqueous compositions were sprayed onto apple trees in San Clemente, Chile, via drone. The test compositions were compared to an untreated control and a typical "kit" application using a Harvista treatment of trees with a soluble composition containing 1.3% 1-MCP (i.e., without a gas containment agent).
[0125] A typical "kit" application using different volumes of 1-MCP-containing aqueous compositions with gas containment agents, as well as an untreated control and a Harvista treatment, was administered via drone (30, 60, 94, and 200 L / ha). Each treatment involved 7 rows of trees, with 20 trees per row, and 8 buffer trees placed between each treatment. Three harvests were performed: commercial harvest (H0), 7 days post-commercial harvest (H+7), and 14 days post-commercial harvest (H+14). Four trees were harvested per harvest. The following parameters were evaluated: hardness, color, starch test, weight, ethylene and respiration evaluation, acidity and soluble solids, and fruit drop.
[0126] The processing group included the following: [Table 26]
[0127] Four trees were used for each treatment per harvest. Each tree was a repeat (R1 to R4), and three harvests were performed: H0 (commercial harvest), H+7 (7 days after commercial harvest), and H+14 (14 days after commercial harvest). In each harvest, the fruits from each tree were separated, and the distribution of cover color was evaluated into four categories (<25%, 25-50%, 50-75%, and <75%). For each color category, the amount of fruit obtained was weighed to determine the optimal potential fruit yield for harvesting.
[0128] Fruits were evaluated under commercial harvest conditions covering 50-75% and >75% of the color zone. Approximately 48 fruits were selected from each color zone for each replicate and distributed as follows: For each covering color zone, 48 fruits were required for each replicate and distributed among four evaluations. 12 fruits were evaluated at harvest, and 12 fruits were evaluated for shelf life evaluation. The remaining 24 fruits were stored at 0°C for 60 days. 12 fruits were evaluated after refrigeration, and the remaining 12 fruits were used for shelf life evaluation after refrigeration.
[0129] For pressure, color, starch, browning, and size, 40 fruits were analyzed for each treatment at each evaluation time (10 fruits per replicate). For ethylene and respiration evaluation, 8 fruits were analyzed for each treatment at each evaluation time (i.e., 2 fruits per replicate). For soluble solids and acidity, a combined sample from each replicate was evaluated. Fruit drop: Fruits were counted from 4 branches of 6 trees per treatment. Fruits on the ground of the harvested trees were also counted.
[0130] Figure 4 shows the color classification of the fruit analyzed in this embodiment. Figure 5 shows the color distribution of the fruit at harvest H0. The following table shows the yield (tons / hectare) for each color classification at harvest H0, along with the separation of the average values of the treatments in each evaluation. [Table 27]
[0131] The table below shows the evaluation of commercial harvest quality and condition at different time intervals from harvest H0, with color classifications ranging from 50% to 75%. A comparison of averages by column is shown. [Table 28]
[0132] The table below shows the ethylene production rate and respiration of commercial harvests at different time evaluations from harvest H0, with color classifications ranging from 50% to 75%. A comparison of the average values for each column is shown. [Table 29]
[0133] The table below shows the evaluation of commercial harvest quality and condition at different time intervals from harvest H0, with color classifications ranging from 75% to 100%. A comparison of averages by column is shown. [Table 30]
[0134] The table below shows the ethylene production rate and respiration of commercially harvested crops at different time evaluations from harvest H0, color-coded from 75% to 100%. A comparison of the average values for each column is shown. [Table 31]
[0135] Figure 6 shows the color distribution of the fruit seven days after commercial harvest (H+7). The table below shows the yield (tons / hectare) for each color category seven days after commercial harvest (H+7), along with the separation of the average values for each treatment in each evaluation. [Table 32]
[0136] The table below shows the quality and condition ratings of the commercial harvest at different time intervals (50-75%) on day 7 after commercial harvest (H+7), categorized by color. A comparison of the average values for each column is shown. [Table 33]
[0137] The table below shows the ethylene production rate and respiration of commercial harvests at different time evaluations on day 7 post-commercial harvest (H+7), categorized by color from 50% to 75%. A comparison of the average values for each column is shown. [Table 34]
[0138] The table below shows the quality and condition ratings of the commercial harvest at different time intervals (75-100%) on day 7 after commercial harvest (H+7), categorized by color. A comparison of the average values for each column is shown. [Table 35]
[0139] The table below shows the ethylene production rate and respiration of commercially harvested crops at different time evaluations on day 7 post-commercial harvest (H+7), categorized by color from 75% to 100%. A comparison of the average values for each column is shown. [Table 36]
[0140] Figure 7 shows the color distribution of the fruit 14 days after commercial harvest (H+14). The table below shows the yield (tons / hectare) for each color category 14 days after commercial harvest (H+14), along with the separation of the average values for each treatment in each evaluation. [Table 37]
[0141] The table below shows the evaluation of the quality and condition of the commercial harvest at different time intervals (75-100%) on day 14 after the commercial harvest (H+14). A comparison of the average values for each column is shown. [Table 38]
[0142] The table below shows the ethylene production rate and respiration of commercially harvested crops at different time evaluations 14 days post-commercial harvest (H+14), categorized by color from 75% to 100%. A comparison of the average values for each column is shown. [Table 39] (Example 19) Additional administration of aqueous composition to apple trees
[0143] This example allows for the evaluation of the effectiveness of various 1-MCP-containing aqueous compositions, including gas containment agents. In particular, this example provides an evaluation of the effectiveness of aqueous compositions containing 1-MCP in combination with α-cyclodextrin as a gas containment agent, as a premixed composition applied to apple trees before harvest to evaluate fruit ripening, fruit drop, and fruit quality.
[0144] Various processing groups can be evaluated, including the following: [Table 40]
[0145] In treatment groups 1-4, 1.8% 1-MCP wettable powder was present in the premixed composition at a concentration of 35%-35% (w / w). Furthermore, α-cyclodextrin was present in the premixed composition at a concentration of 55%-65% (w / w), and EDTA was present at a concentration of 1% (w / w).
[0146] The treatment groups can be administered via a backpack sprayer or by drone spraying. Depending on the treatment, the exact amount of water was measured and gently added to the sprayer to dilute the premixed composition before administration. The actual water usage was as follows: [Table 41]
[0147] The analysis can be carried out as follows: After each harvest, the collected fruits can be divided into two groups. One group can be used for fruit attribute analysis on the day of harvest. The other group can be kept at room temperature (22°C to 22°C) for 14 days to evaluate changes in fruit attributes during room temperature storage (on a shelf).
[0148] In each evaluation, 25 fruits can be collected for each iteration of each treatment. Before harvest, plant toxicity, plant growth status, and leaf and fruit residues can be examined. At harvest, the fruit drop rate can be analyzed by counting the number of fallen fruits from each section and calculating the fruit drop rate (%). After harvest and during shelf storage, measurements may include fruit hardness, total soluble solids, total acidity, average fruit weight, and ethylene release. Starch staining index, peel color, peel ground color, appearance defects, honeycombing, and bitter pox can also be evaluated. The flavor of the fruit can also be tasted.
[0149] In the case of fruit starch staining, 10 fruits can be randomly selected from each replicate of the starch staining by using potassium iodide. The starch staining index can be graded on an 8-point scale.
[0150] The total acidity in the fruit can be determined by GB / T12456-90. Fruit hardness can be measured using a GS-15 fruit tissue analyzer. For each fruit measurement, two locations along the fruit's equator can be selected and measured after peeling (units: kg / cm2).
[0151] For total soluble solid fruit, a PR-101α Brix refractometer can be used (unit (%)). For fruit rot, each measurement allows for the counting of rotten fruit in each treatment group. Peel color can be evaluated and recorded. Peel color can be graded in 5 stages: Stage 0: No redness, Stage 1: Redness area ≤ 30%, Stage 2: Redness area 30%~60%, Stage 3: 60%~90%, Stage 4: Redness area > 90%. Peel color index = Σ(number of fruits from each stage × number of stages) / total number of fruits.
[0152] The fruit's surface color can be evaluated and recorded at each measurement. For example, 0 means green, 1 means yellowish-green, 2 means yellowish-green / yellow, and 3 means yellow / brown.
[0153] Fruit dehydration can be assessed by observing and evaluating the fruit's water loss at each measurement. For example, 0 means saturation, 1 means slight dehydration, 2 means moderate dehydration, and 3 means severe dehydration. Water loss can also be obtained by marking the fruit and then measuring the fruit on day 1 and on the measurement day, after which the water loss (%) can be calculated.
[0154] Physiological disorders and flavor tasting can be evaluated. Finally, chemical effects can be assessed to determine crop safety.
Claims
1. an aqueous composition comprising i) 1-MCP, ii) a gas scavenger, and iii) water.
2. An aqueous composition according to claim 1, characterized in that the 1-MCP is included in the complex, the complex is an inclusion compound, and the inclusion compound contains alpha-cyclodextrin.
3. An aqueous composition according to claim 1, characterized in that the composite is pulverized by air.
4. An aqueous composition according to claim 1, characterized in that the composite is solubilized in the aqueous composition.
5. An aqueous composition according to claim 1, characterized in that the 1-MCP is contained in the solution.
6. An aqueous composition according to claim 1, characterized in that the 1-MCP is contained in the powder.
7. The aqueous composition according to claim 1, characterized in that the gas scavenger is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieve, and any combination thereof.
8. An aqueous composition according to claim 1, characterized in that the gas scavenging agent comprises alphacyclodextrin.
9. An aqueous composition according to claim 1, characterized in that the gas scavenger is in an amount of about 1% to about 10% by weight of the water in the aqueous composition.
10. An aqueous composition according to claim 1, characterized in that the gas scavenging agent is approximately 5% by weight of the water in the aqueous composition.
11. An aqueous composition according to claim 1, characterized in that the total amount of 1-MCP in the aqueous composition is maintained at at least 10% by weight of the initial amount of 1-MCP for 24 hours.
12. i) A solid composition comprising 1-MCP and ii) a gas scavenger.
13. A solid composition according to claim 12, characterized in that the 1-MCP is included in the complex, the complex is an inclusion compound, and the inclusion compound contains alpha-cyclodextrin.
14. A solid composition according to claim 12, characterized in that the 1-MCP is contained in the powder.
15. A solid composition according to claim 14, characterized in that the powder is a wettable agent.
16. A solid composition according to claim 12, characterized in that the gas scavenger is selected from the group consisting of alpha-cyclodextrin, activated carbon (charcoal), activated carbon (carbon), porous silica, molecular sieve, and any combination thereof.
17. A solid composition according to claim 12, characterized in that the gas scavenging agent contains alphacyclodextrin.
18. A method for preparing an aqueous composition, e) Add water to the container, f) Adding a gas scavenging agent to the container, g) The step of adding 1-MCP to the container, and h) A step of mixing the water, the gas scavenger, and the 1-MCP to form the aqueous composition. Methods that include...
19. A method according to claim 18, characterized in that step c) is performed simultaneously with step b).
20. A method according to claim 18, characterized in that step c) is performed after step b).
21. A method according to claim 18, characterized in that the mixing is carried out until the aqueous composition is homogeneous.
22. A method according to claim 18, characterized in that the 1-MCP is included in the complex, the complex is an inclusion compound, and the inclusion compound contains alpha-cyclodextrin.
23. A method according to claim 22, characterized in that the composite is present in a concentration of about 0.5% to about 10% by weight of the aqueous composition.
24. A method according to claim 18, characterized in that the 1-MCP is contained in the solution.
25. A method according to claim 18, characterized in that the 1-MCP is contained in a powder and the powder is a wettable agent.
26. A method according to claim 18, characterized in that the gas scavenging agent comprises alphacyclodextrin.
27. A method according to claim 18, characterized in that the gas scavenger is in an amount of about 1% to about 10% by weight of the water in the aqueous composition.
28. A method according to claim 18, characterized in that the gas scavenging agent is in an amount of about 3% to about 10% by weight of the water in the aqueous composition.
29. A method according to claim 18, characterized in that the gas scavenging agent is about 5% by weight of the water in the aqueous composition.
30. A method for applying an aqueous composition to a plant or part of a plant, wherein the method comprises the step of administering the aqueous composition to the plant or part of a plant via an agricultural tool, the aqueous composition being the aqueous composition according to any one of claims 1 to 11.
31. A method according to claim 30, characterized in that the agricultural machinery includes a ground spraying device.
32. A method according to claim 30, characterized in that the agricultural machinery includes an aerial spraying device.
33. A method according to claim 30, characterized in that the agricultural machinery includes a drone spraying device.
34. A method according to claim 30, characterized in that the agricultural machinery includes a backpack-type spraying device.
35. A method according to claim 30, characterized in that the agricultural equipment includes a spray tank or container.
36. A method according to claim 35, characterized in that the spray tank or container is ventilated.
37. A method according to claim 30, characterized in that the aqueous composition is prepared in situ.